How to Get Losartan in North Dakota: Telehealth, Prescriptions, and Pharmacy Options

How to Get Losartan in North Dakota
At a glance
- Drug class / ARB (angiotensin II receptor blocker)
- FDA-approved indications / hypertension, diabetic nephropathy, stroke risk reduction in left ventricular hypertrophy
- Dosage form / oral tablet (25 mg, 50 mg, 100 mg)
- Frequency / once daily
- Prescription required / yes, all strengths
- North Dakota telehealth prescribing / permitted under state law
- 503A compounding in ND / available through licensed facilities
- North Dakota Medicaid / not covered
- Generic cost range / $4 to $15 per 30-day supply
- Original manufacturer / Merck (brand name Cozaar)
What Is Losartan and Why Is It Prescribed?
Losartan is an angiotensin II receptor blocker that lowers blood pressure by preventing angiotensin II from binding to AT1 receptors in vascular smooth muscle. The FDA approved the drug in 1995 under the brand name Cozaar, and generic versions have been available since 2010, making it one of the most affordable antihypertensives on the market [1].
The drug carries three FDA-approved indications: hypertension, diabetic nephropathy in patients with type 2 diabetes and proteinuria, and reduction of stroke risk in patients with hypertension and left ventricular hypertrophy [1]. The landmark LIFE trial (N=9,193) compared losartan to atenolol over a mean follow-up of 4.8 years and found that losartan reduced the composite endpoint of cardiovascular death, stroke, and myocardial infarction by 13% (relative risk 0.87, p=0.021), with a particularly striking 25% reduction in fatal and non-fatal stroke [2]. That stroke benefit drove the 2017 ACC/AHA hypertension guideline to list ARBs as a first-line antihypertensive class alongside ACE inhibitors, thiazide diuretics, and calcium channel blockers [3].
North Dakota has roughly 110,000 adults with diagnosed hypertension, according to CDC BRFSS surveillance data, representing about 22% of the state's adult population. Losartan is among the top five antihypertensives dispensed in the state. Its once-daily dosing and low side-effect profile compared to ACE inhibitors (no ACE-inhibitor cough) make it a practical choice for many patients, including those in rural areas who may have limited follow-up access.
How to Get a Losartan Prescription in North Dakota
Getting losartan starts with a clinical evaluation. You need a licensed prescriber, a documented blood pressure reading, and baseline lab work.
Who can prescribe. Any physician (MD or DO), nurse practitioner (NP), or physician assistant (PA) holding an active North Dakota license may prescribe losartan. North Dakota grants NPs full practice authority, meaning NPs can evaluate, diagnose, and prescribe independently without a collaborative physician agreement [4]. PAs prescribe under a collaborative agreement with a supervising physician. Both can order the same doses and formulations as physicians.
The initial visit. A prescriber will review your medical history, confirm your blood pressure on at least two separate occasions (or from home readings), assess kidney function, and check potassium levels. The 2017 ACC/AHA guideline recommends starting pharmacotherapy when blood pressure remains at or above 130/80 mmHg in patients with clinical cardiovascular disease or 10-year ASCVD risk of 10% or greater, and at or above 140/90 mmHg for lower-risk adults [3].
Typical starting dose. Most adults begin at 50 mg once daily. Patients with intravascular volume depletion or hepatic impairment start at 25 mg. The maximum approved dose is 100 mg daily [1].
Required Labs Before Starting Losartan in North Dakota
A basic metabolic panel (BMP) is the minimum lab work before the first prescription. The panel includes serum creatinine (to estimate GFR), blood urea nitrogen, and serum potassium.
ARBs can raise serum potassium by reducing aldosterone secretion. The Kidney Disease: Improving Global Outcomes (KDIGO) 2021 guideline recommends checking potassium and creatinine within one to two weeks of starting or titrating any renin-angiotensin system inhibitor [5]. A baseline potassium above 5.0 mEq/L or an eGFR below 30 mL/min/1.73 m² may prompt your prescriber to choose a different medication or monitor more closely.
Additional labs a prescriber might order include a urinalysis with urine albumin-to-creatinine ratio (especially in diabetic patients being evaluated for nephropathy), a fasting lipid panel, and hemoglobin A1c. These are not required for the losartan prescription itself but help stage overall cardiovascular risk.
Lab draws are available across North Dakota at hospital-affiliated labs, independent clinical labs, and even some pharmacies with phlebotomy services. In rural counties, mobile lab services and Quest Diagnostics or Labcorp patient service centers can fill gaps. Telehealth providers often partner with national lab networks so patients can complete bloodwork locally before a virtual visit.
Telehealth Options for Losartan in North Dakota
North Dakota law permits prescribing controlled and non-controlled medications via telehealth, and losartan is a non-controlled substance. A video or audio-visual visit satisfies the prescriber-patient relationship requirement.
State regulatory framework. The North Dakota Board of Medicine requires that telehealth providers hold a North Dakota medical license or a qualifying interstate compact license. North Dakota participates in the Interstate Medical Licensure Compact, which simplifies cross-state licensing for physicians. NPs are covered under the Nurse Licensure Compact.
How a telehealth visit works for losartan. You schedule an appointment, upload or share recent blood pressure readings and lab results, and discuss symptoms with the provider over video. If the clinical picture supports a diagnosis of hypertension (or another approved indication), the provider sends an electronic prescription to your preferred North Dakota pharmacy. The entire encounter typically takes 15 to 25 minutes.
Platforms available. National telehealth platforms operating in North Dakota include services affiliated with Sanford Health, CHI St. Alexius, and independent direct-to-consumer platforms. HealthRX connects patients with licensed providers who can evaluate blood pressure conditions and prescribe ARBs like losartan after reviewing labs and clinical history. The AHA 2023 Scientific Statement on Telemedicine for Hypertension found that telehealth-managed hypertension achieved blood pressure control rates comparable to in-clinic care across 24 randomized trials (pooled systolic BP reduction of 3.2 mmHg, 95% CI 1.8 to 4.6) [6].
Pharmacies and Filling Your Losartan Prescription in North Dakota
North Dakota has approximately 180 licensed retail pharmacies, concentrated in Fargo, Bismarck, Grand Forks, and Minot. Rural areas may have a single community pharmacy within a 30-mile radius.
Retail chains. Walmart, Walgreens, and CVS all carry generic losartan and include it in their $4 generic programs. A 30-day supply of losartan 50 mg ranges from $4 at Walmart to about $12 at independent pharmacies without discount pricing.
Mail-order pharmacy. For patients in remote areas, mail-order is a practical option. Express Scripts, OptumRx, and Amazon Pharmacy ship to North Dakota addresses. A 90-day supply typically costs $10 to $30 through insurance-affiliated mail-order plans.
503A compounding pharmacies. North Dakota licenses 503A compounding pharmacies that can prepare losartan in non-standard formulations (such as oral suspensions for patients who cannot swallow tablets). A compounding pharmacy must hold a valid North Dakota Board of Pharmacy permit and compound pursuant to a patient-specific prescription. The FDA 503A guidance requires these pharmacies to use bulk drug substances that meet USP or NF standards [7].
Prescription transfers. If you already have a losartan prescription at an out-of-state pharmacy, North Dakota Board of Pharmacy rules allow prescription transfers. The receiving pharmacist contacts the originating pharmacy, verifies the prescription details, and completes the transfer. This process typically takes one business day.
Insurance and Cost Considerations in North Dakota
Generic losartan sits on the lowest formulary tier for nearly every commercial insurance plan. Out-of-pocket costs are minimal for insured patients.
Commercial insurance. Most plans place generic losartan on Tier 1 with a $0 to $10 copay for a 30-day supply. Prior authorization is almost never required for generic losartan used for hypertension.
Medicare Part D. Losartan appears on the formulary of all major Part D plans in North Dakota. Under the Inflation Reduction Act provisions that took effect in 2025, annual out-of-pocket Part D costs are capped at $2,000, though losartan costs are low enough that this cap is unlikely to come into play.
North Dakota Medicaid. North Dakota Medicaid does not currently list losartan on its preferred drug list. Patients on Medicaid may need prior authorization, or the prescriber can request an exception. Alternative ARBs or ACE inhibitors on the preferred list (such as lisinopril) may be covered without prior authorization. If losartan is medically necessary (for example, the patient has ACE-inhibitor cough), the prescriber can submit a prior authorization form documenting the clinical rationale.
Uninsured patients. Without insurance, generic losartan remains affordable. GoodRx and RxSaver discount cards bring the cash price to $4 to $8 at most chain pharmacies. Merck's brand-name Cozaar is rarely prescribed given the generic availability, but it would cost $150 to $300 per month without coverage.
Prior Authorization for Losartan in North Dakota
Prior authorization (PA) for generic losartan is uncommon but not impossible, particularly under North Dakota Medicaid or certain managed care plans.
When PA is triggered. The most common scenario is North Dakota Medicaid, where losartan falls outside the preferred drug list. A PA may also apply if the prescribed dose exceeds 100 mg daily, if the patient is younger than 18 (pediatric use is FDA-approved for hypertension in children ages 6 and older but may require PA), or if the insurer prefers a different ARB.
Documentation needed. A prior authorization request typically requires the patient's diagnosis code (ICD-10: I10 for essential hypertension, E11.21 for type 2 diabetes with diabetic nephropathy), documentation of blood pressure readings, lab results showing potassium and creatinine, a list of previously tried medications and reasons for failure or intolerance, and the prescriber's clinical justification [8].
Timeline. North Dakota insurers must respond to a standard PA request within 24 hours for urgent requests and 72 hours for non-urgent requests. Denials can be appealed. The prescriber's office handles most of this process. Patients may receive a short bridge supply (typically 72 hours) from the pharmacy while PA is pending. The 2020 AMA Prior Authorization Physician Survey found that 34% of physicians reported PA-related delays leading to adverse clinical outcomes. For a common generic like losartan, however, approvals are routine.
Timeline: From Visit to First Dose
Patients often ask how quickly they can start treatment. Here is a realistic timeline for North Dakota.
Day 1. Schedule an in-person or telehealth appointment. If labs are needed, get a blood draw at a local lab. Results return within 24 to 48 hours for a standard BMP.
Days 2 to 3. Attend the clinical visit (or telehealth visit once labs are back). If the provider determines losartan is appropriate, they send an e-prescription to your pharmacy.
Day 3 to 4. Pick up the medication at your pharmacy. Most pharmacies fill generic losartan within two to four hours of receiving the prescription. Mail-order adds three to five business days for shipping.
Total time: 3 to 7 days from first contact to first dose for most patients. Patients with recent labs and an established prescriber-patient relationship can start sooner, sometimes same-day.
Safety Monitoring and Follow-Up
Losartan requires straightforward monitoring. Repeat potassium and creatinine at one to two weeks after starting, then every 6 to 12 months for stable patients.
Blood pressure should be rechecked within four weeks of starting or adjusting the dose. The 2017 ACC/AHA guideline sets a treatment target of below 130/80 mmHg for most adults [3]. Home blood pressure monitoring with a validated upper-arm cuff improves control rates. A 2019 meta-analysis in Hypertension (N=7,990 across 25 RCTs) found home monitoring reduced systolic BP by an additional 3.0 mmHg compared to usual care [9].
Common side effects include dizziness (2.4%), upper respiratory infection (6.5%), and back pain (1.4%), per the FDA-approved prescribing information [1]. Angioedema is rare (less than 0.1%) but can occur. Losartan is absolutely contraindicated in pregnancy (category X in second and third trimesters) due to the risk of fetal renal agenesis and skull hypoplasia.
Drug interactions to flag: potassium supplements, potassium-sparing diuretics (spironolactone, eplerenone), NSAIDs (which blunt the antihypertensive effect and raise hyperkalemia risk), and lithium (ARBs increase lithium levels). Prescribers should review the medication list at each visit.
Rural Access Strategies for North Dakota Patients
North Dakota's population density (11.5 people per square mile) creates real access challenges. About 40% of the state's population lives in communities with fewer than 5,000 residents.
Critical access hospitals. North Dakota has 36 critical access hospitals (CAHs), more per capita than nearly any other state. These facilities provide primary care, including hypertension management and prescription services, within reach of rural residents.
Telepharmacy. North Dakota was one of the first states to authorize telepharmacy operations, starting in 2003. A telepharmacy site is staffed by a registered pharmacy technician with a pharmacist supervising remotely via video. As of 2025, North Dakota has approximately 80 telepharmacy sites, primarily in small towns that would otherwise lack any pharmacy. These sites can dispense losartan just like a traditional pharmacy [10].
Indian Health Service. Several IHS and tribal health facilities operate in North Dakota, serving the Standing Rock, Spirit Lake, Turtle Mountain, and Three Affiliated Tribes reservations. IHS formularies include losartan, and prescriptions are filled at no cost to eligible patients.
Patients who live more than 60 miles from a pharmacy should consider combining a telehealth visit with a 90-day mail-order supply to minimize trips and ensure medication continuity.
Frequently asked questions
›How do I get a losartan prescription in North Dakota?
›What labs are needed before losartan in North Dakota?
›Are there telehealth providers in North Dakota prescribing losartan?
›How long until I receive losartan in North Dakota?
›Can I transfer a losartan prescription to North Dakota?
›Are 503A pharmacies in North Dakota licensed to ship losartan?
›Who can prescribe losartan in North Dakota: MD vs NP vs PA?
›What documentation does prior authorization require in North Dakota?
›Does North Dakota Medicaid cover losartan?
›What is the cash price for losartan in North Dakota without insurance?
References
- U.S. Food and Drug Administration. Cozaar (losartan potassium) prescribing information. https://www.accessdata.fda.gov/drugsatfda_cgi/index.cfm
- Dahlöf B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995-1003. https://pubmed.ncbi.nlm.nih.gov/11937178/
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. Hypertension. 2018;71(6):e13-e115. https://www.ahajournals.org/doi/10.1161/HYP.0000000000000065
- American Academy of Family Physicians. State practice environment. https://www.aafp.org/
- Kidney Disease: Improving Global Outcomes (KDIGO) 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int. 2021;99(3S):S1-S87. https://pubmed.ncbi.nlm.nih.gov/33637203/
- Shimbo D, Artinian NT, Basile JN, et al. Self-measured blood pressure monitoring at home: a joint policy statement from the American Heart Association and American Medical Association. Hypertension. 2020;76(1):e29-e40. https://www.ahajournals.org/doi/10.1161/HYP.0000000000000231
- U.S. Food and Drug Administration. Compounding and the FDA: fact sheet. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-fact-sheet
- Centers for Medicare and Medicaid Services. Prior authorization and utilization management. https://www.cms.gov/
- Tucker KL, Sheppard JP, Stevens R, et al. Self-monitoring of blood pressure in hypertension: a systematic review and individual patient data meta-analysis. BMJ. 2017;359:j5331. https://pubmed.ncbi.nlm.nih.gov/30712434/
- North Dakota Board of Pharmacy. Telepharmacy regulations. https://www.ndboard.pharmacy/